# Pharmacological Management of Pain In Alzheimer's Disease and Related Dementia

> **NIH NIH K01** · UNIVERSITY OF FLORIDA · 2020 · $51,331

## Abstract

Summary: My career goal is to become an independent geriatric pharmacoepidemiologist with expertise in
pharmacotherapy quality measurement and outcomes evaluation in the fields of pain and aging. The clinical
focus of my research has centered on the management of multi-morbidity in older adults and particularly, the
interplay of mental and physical disease and its treatment. One example of combination of health problems is
elderly patients who live with Alzheimer's disease and related dementia (ADRD) and also suffer from chronic
pain. To date, data on quality of pain medication prescribing and the sequelae of poor pain control in patients
with ADRD are scarce. Studies investigating these associations are limited by small sample size, and none has
attempted to establish the effect of adequate pain control on preventing mental health (MH) disorders. The
goal of my K01 proposed research is to provide preliminary data that improve our understanding of current
pain medication prescribing and potential discrepancies between practices and pain guidelines, and to
formulate hypotheses for future research regarding the role of pain control in reducing MH problems in ADRD.
We propose a longitudinal design using 4 years (2011-2014) of Medicare 5% sample whose billing records are
linked to nursing home resident assessment data (Minimum Data Set, MDS, 3.0). Because it is unclear
whether MDS 3.0 can accurately detect patients with pain and MH disorders, we first conduct a feasibility study
of validating MDS-based pain, depression, and behavioral symptoms against medical records at two nursing
homes (Aim 1). With the nationally representative Medicare-MDS data, we explore the quality of
pharmacological pain management and its determinants among ADRD and non-ADRD residents with non-
cancer pain (Aim 2). The quality will be examined based on five common clinical standards--pain medication
selection, pain medication scheduling, pharmacological prevention of drug adverse event, contraindicated
medication use, and overall pain control. We then explore the extent to which pain control is associated with a
decreased risk for select MH disorders, including depression, behavioral symptoms, anxiety, and sleep
disorders in ADRD (Aim 3). This project is well tailored for me to apply the knowledge and skills that will be
obtained from training activities with my Primary Mentor, Dr. Almut Winterstein (pharmacoepidemioloy, quality
measurement and outcome assessment) and Co-Mentors: Drs. Roger Fillingim (pain), Marco Pahor (aging),
Babette Brumback (advanced methods for longitudinal data), and Laurence Solberg (clinical geriatric care and
assessment). For further guidance, I enlist the expertise of Dr. Siegfried Schmidt in the field of pain medicine
and Dr. Steven DeKosky in ADRD. This K01 award will provide protected time for me to receive training
needed to prepare an R01 grant application to examine pain medication practices and their impact on health
outcomes in ADRD. The r...

## Key facts

- **NIH application ID:** 10161046
- **Project number:** 3K01AG054764-04S1
- **Recipient organization:** UNIVERSITY OF FLORIDA
- **Principal Investigator:** Yu-Jung “Jenny” Wei
- **Activity code:** K01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $51,331
- **Award type:** 3
- **Project period:** 2017-08-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10161046

## Citation

> US National Institutes of Health, RePORTER application 10161046, Pharmacological Management of Pain In Alzheimer's Disease and Related Dementia (3K01AG054764-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10161046. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*